CD4 and breast cancer: cite evidence for multiple documented cytolytic effector molecules expressed by CD4+ T cells in various cancer models of non-small-cell lung cancer, colorectal cancer, hepatocellular carcinoma, bladder cancer, osteosarcoma, breast cancer, and head and neck cancer, although the individual roles of some have not yet been directly tested (18).